City
Epaper

No need of booster dose for now: AIIMS Director

By IANS | Updated: November 23, 2021 23:20 IST

New Delhi, Nov 23 All India Institute of Medical Sciences (AIIMS) Director Randeep Guleria on Tuesday said India ...

Open in App

New Delhi, Nov 23 All India Institute of Medical Sciences (AIIMS) Director Randeep Guleria on Tuesday said India does not need booster dose at this time.

Guleria said that there is no surge in cases as such at the moment which suggests that vaccines are still protecting against the coronavirus.

He said: "There is no need for a vaccine booster dose or third dose for now."

"It is unlikely that a third wave of Covid-19 of a magnitude comparable to the first and second will hit India. With time the pandemic will take an endemic form. We'll continue to get cases but the severity will be highly reduced," he added.

Dr. Guleria was speaking at the launch of a book "Going Viral: Making of Covaxin - The Inside Story" which has been authored by Indian Council of Medical Research Director General Dr Balram Bhargava.

The AIIMS director said that when H1N1 had hit India, vaccines were imported from foreign countries. "From importing vaccines to manufacturing our own indigenous vaccine, we have come a long way. Today, our Covid vaccines are being exported to other countries,"

On the need of Covid booster dose, NITI Aayog member (Health) Dr. VK Paul said the decision on a third dose should be based on science.

The book 'Going Viral...' is an attempt to take readers through the journey of developing India's first indigenous Covid-19 vaccine. The book captures the first-hand experiences of scientists who worked round the clock to develop India's first indigenous Covid-19 vaccine in a record time of less than eight months. The book sheds light on the resilience and courage depicted.

Talking about his book, Dr. Bhargava said: "The development of India's indigenous vaccine Covaxin is a true example of public private-partnership marked with trust and and transparency."

In his book, Prof (Dr.) Bhargava has also brought to the forefront some lesser-known facts behind the making of Covaxin including the innovative ways in which scientists navigated a strict nationwide lockdown to conduct India's first seroprevalence survey. In another anecdote, the author has highlighted the important role played by 20 monkeys in ensuring that millions of Ind across the country have access to this life-saving vaccine.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Tags: V.K PaulindiaNew DelhiAll India Institute Of Medical SciencesAiimsRandeep GuleriaThe new delhi municipal councilDelhi south-westIndiUk-indiaRepublic of india
Open in App

Related Stories

CricketIndia vs South Africa 2025 Schedule: Full List of Matches, Dates, Venues and Fixtures

TechnologyOpenAI Offers ChatGPT Go Free for a Year in India; Check All the Features Users Can Now Access

NationalGolden Power: Indian Women Now Hold 24,000 Tonnes of Gold, Outshining Global Investors

MumbaiMumbai Man Pursuing PhD in US Booked for Sexually Abusing Woman on False Promise of Marriage

LifestyleCreative Rangoli Designs for Dhanteras and Diwali 2025 to Welcome Goddess Lakshmi

Health Realted Stories

HealthNew genetic tool reveals chromosome changes linked to pregnancy loss: Study

HealthHypertension affects brain much earlier than expected: Study

HealthFive people die of dengue in Bangladesh, 2025 death toll crosses 330

HealthK'taka blackbuck death toll rises to 29; initial probe points to bacterial infection

HealthAyurveda’s global relevance reinforced via advancing scientific research: Dinesh Bhatia